Cardiac Monitoring & Cardiac Rhythm Management - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509248090

Publication Date:

September 18, 2024

Pages:

148

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Cardiac monitoring (CM) devices help in continuous examination of a patient鈥檚 cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs, and certain genetic errors among others.
The global market for Cardiac Monitoring & Cardiac Rhythm Management was estimated to be worth US$ 23820 million in 2023 and is forecast to a readjusted size of US$ 31280 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030
The market is driven by factors such as growing incidence of cardiac disorders, technological advancements, patient awareness, and increasing number of unmet medical needs in developing and underdeveloped countries. Conversely, the market is hampered by limited insurance coverage options; high cost of these devices, especially in developing nations; and preference for drugs over treatment devices. However, the development of new MRI-labeled devices and growth opportunities in the emerging economies of Asia-Pacific and LAMEA regions are expected to provide opportunities for growth of cardiac monitoring & cardiac rhythm management industry during the forecast period.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiac Monitoring & Cardiac Rhythm Management, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cardiac Monitoring & Cardiac Rhythm Management by region & country, by Type, and by Application.
The Cardiac Monitoring & Cardiac Rhythm Management market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Monitoring & Cardiac Rhythm Management.
麻豆原创 Segmentation
By Company
Abiomed, Inc.
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
Cardiac Science Corporation
General Electric Company (GE)
Hill-Rom Holdings, Inc.
Jarvik Heart, Inc.
Koninklijke Philips N.V.
LivaNova PLC
Medtronic plc
Nihon Kohden Corporation
ReliantHeart Inc.
SCHILLER AG
Abbott
Siemens AG
3M Company
Asahi Kasei Corporation
Stryker Corporation
Mortara Instrument, Inc.
OSI Systems, Inc.
Cardionet Inc.
Segment by Type:
Electrocardiogram (ECG) Devices
Implantable Loop Recorders (ILR)
Cardiac Output Monitoring (COM) Devices
Event Monitors
Pacemakers
Cardiac Resynchronization Therapy (CRT) Devices
Defibrillator
External Defibrillator
Ventricular Assist Devices (VADs)
Segment by Application
Hospitals & Clinics
麻豆原创 Settings
Ambulatory Surgical Centers (ASCs)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiac Monitoring & Cardiac Rhythm Management manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cardiac Monitoring & Cardiac Rhythm Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cardiac Monitoring & Cardiac Rhythm Management in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Cardiac Monitoring & Cardiac Rhythm Management Product Introduction
1.2 Global Cardiac Monitoring & Cardiac Rhythm Management 麻豆原创 Size Forecast
1.3 Cardiac Monitoring & Cardiac Rhythm Management 麻豆原创 Trends & Drivers
1.3.1 Cardiac Monitoring & Cardiac Rhythm Management Industry Trends
1.3.2 Cardiac Monitoring & Cardiac Rhythm Management 麻豆原创 Drivers & Opportunity
1.3.3 Cardiac Monitoring & Cardiac Rhythm Management 麻豆原创 Challenges
1.3.4 Cardiac Monitoring & Cardiac Rhythm Management 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cardiac Monitoring & Cardiac Rhythm Management Players Revenue Ranking (2023)
2.2 Global Cardiac Monitoring & Cardiac Rhythm Management Revenue by Company (2019-2024)
2.3 Key Companies Cardiac Monitoring & Cardiac Rhythm Management Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cardiac Monitoring & Cardiac Rhythm Management Product Offered
2.5 Key Companies Time to Begin Mass Production of Cardiac Monitoring & Cardiac Rhythm Management
2.6 Cardiac Monitoring & Cardiac Rhythm Management 麻豆原创 Competitive Analysis
2.6.1 Cardiac Monitoring & Cardiac Rhythm Management 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cardiac Monitoring & Cardiac Rhythm Management Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Monitoring & Cardiac Rhythm Management as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Electrocardiogram (ECG) Devices
3.1.2 Implantable Loop Recorders (ILR)
3.1.3 Cardiac Output Monitoring (COM) Devices
3.1.4 Event Monitors
3.1.5 Pacemakers
3.1.6 Cardiac Resynchronization Therapy (CRT) Devices
3.1.7 Defibrillator
3.1.8 External Defibrillator
3.1.9 Ventricular Assist Devices (VADs)
3.2 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Type
3.2.1 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value, by Type (2019-2030)
3.2.3 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals & Clinics
4.1.2 麻豆原创 Settings
4.1.3 Ambulatory Surgical Centers (ASCs)
4.2 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Application
4.2.1 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value, by Application (2019-2030)
4.2.3 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Region
5.1.1 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Region (2019-2024)
5.1.3 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Region (2025-2030)
5.1.4 Global Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
5.2.2 North America Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
5.3.2 Europe Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
5.4.2 Asia Pacific Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
5.5.2 South America Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
5.6.2 Middle East & Africa Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cardiac Monitoring & Cardiac Rhythm Management Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cardiac Monitoring & Cardiac Rhythm Management Sales Value
6.3 United States
6.3.1 United States Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
6.3.2 United States Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
6.4.2 Europe Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
6.5.2 China Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
6.6.2 Japan Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
6.7.2 South Korea Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
6.8.2 Southeast Asia Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cardiac Monitoring & Cardiac Rhythm Management Sales Value, 2019-2030
6.9.2 India Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cardiac Monitoring & Cardiac Rhythm Management Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abiomed, Inc.
7.1.1 Abiomed, Inc. Profile
7.1.2 Abiomed, Inc. Main Business
7.1.3 Abiomed, Inc. Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.1.4 Abiomed, Inc. Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.1.5 Abiomed, Inc. Recent Developments
7.2 Berlin Heart GmbH
7.2.1 Berlin Heart GmbH Profile
7.2.2 Berlin Heart GmbH Main Business
7.2.3 Berlin Heart GmbH Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.2.4 Berlin Heart GmbH Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.2.5 Berlin Heart GmbH Recent Developments
7.3 Biotronik SE & Co. KG
7.3.1 Biotronik SE & Co. KG Profile
7.3.2 Biotronik SE & Co. KG Main Business
7.3.3 Biotronik SE & Co. KG Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.3.4 Biotronik SE & Co. KG Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.3.5 Boston Scientific Corporation Recent Developments
7.4 Boston Scientific Corporation
7.4.1 Boston Scientific Corporation Profile
7.4.2 Boston Scientific Corporation Main Business
7.4.3 Boston Scientific Corporation Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.4.4 Boston Scientific Corporation Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.4.5 Boston Scientific Corporation Recent Developments
7.5 Cardiac Science Corporation
7.5.1 Cardiac Science Corporation Profile
7.5.2 Cardiac Science Corporation Main Business
7.5.3 Cardiac Science Corporation Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.5.4 Cardiac Science Corporation Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.5.5 Cardiac Science Corporation Recent Developments
7.6 General Electric Company (GE)
7.6.1 General Electric Company (GE) Profile
7.6.2 General Electric Company (GE) Main Business
7.6.3 General Electric Company (GE) Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.6.4 General Electric Company (GE) Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.6.5 General Electric Company (GE) Recent Developments
7.7 Hill-Rom Holdings, Inc.
7.7.1 Hill-Rom Holdings, Inc. Profile
7.7.2 Hill-Rom Holdings, Inc. Main Business
7.7.3 Hill-Rom Holdings, Inc. Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.7.4 Hill-Rom Holdings, Inc. Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.7.5 Hill-Rom Holdings, Inc. Recent Developments
7.8 Jarvik Heart, Inc.
7.8.1 Jarvik Heart, Inc. Profile
7.8.2 Jarvik Heart, Inc. Main Business
7.8.3 Jarvik Heart, Inc. Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.8.4 Jarvik Heart, Inc. Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.8.5 Jarvik Heart, Inc. Recent Developments
7.9 Koninklijke Philips N.V.
7.9.1 Koninklijke Philips N.V. Profile
7.9.2 Koninklijke Philips N.V. Main Business
7.9.3 Koninklijke Philips N.V. Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.9.4 Koninklijke Philips N.V. Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.9.5 Koninklijke Philips N.V. Recent Developments
7.10 LivaNova PLC
7.10.1 LivaNova PLC Profile
7.10.2 LivaNova PLC Main Business
7.10.3 LivaNova PLC Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.10.4 LivaNova PLC Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.10.5 LivaNova PLC Recent Developments
7.11 Medtronic plc
7.11.1 Medtronic plc Profile
7.11.2 Medtronic plc Main Business
7.11.3 Medtronic plc Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.11.4 Medtronic plc Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.11.5 Medtronic plc Recent Developments
7.12 Nihon Kohden Corporation
7.12.1 Nihon Kohden Corporation Profile
7.12.2 Nihon Kohden Corporation Main Business
7.12.3 Nihon Kohden Corporation Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.12.4 Nihon Kohden Corporation Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.12.5 Nihon Kohden Corporation Recent Developments
7.13 ReliantHeart Inc.
7.13.1 ReliantHeart Inc. Profile
7.13.2 ReliantHeart Inc. Main Business
7.13.3 ReliantHeart Inc. Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.13.4 ReliantHeart Inc. Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.13.5 ReliantHeart Inc. Recent Developments
7.14 SCHILLER AG
7.14.1 SCHILLER AG Profile
7.14.2 SCHILLER AG Main Business
7.14.3 SCHILLER AG Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.14.4 SCHILLER AG Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.14.5 SCHILLER AG Recent Developments
7.15 Abbott
7.15.1 Abbott Profile
7.15.2 Abbott Main Business
7.15.3 Abbott Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.15.4 Abbott Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.15.5 Abbott Recent Developments
7.16 Siemens AG
7.16.1 Siemens AG Profile
7.16.2 Siemens AG Main Business
7.16.3 Siemens AG Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.16.4 Siemens AG Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.16.5 Siemens AG Recent Developments
7.17 3M Company
7.17.1 3M Company Profile
7.17.2 3M Company Main Business
7.17.3 3M Company Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.17.4 3M Company Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.17.5 3M Company Recent Developments
7.18 Asahi Kasei Corporation
7.18.1 Asahi Kasei Corporation Profile
7.18.2 Asahi Kasei Corporation Main Business
7.18.3 Asahi Kasei Corporation Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.18.4 Asahi Kasei Corporation Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.18.5 Asahi Kasei Corporation Recent Developments
7.19 Stryker Corporation
7.19.1 Stryker Corporation Profile
7.19.2 Stryker Corporation Main Business
7.19.3 Stryker Corporation Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.19.4 Stryker Corporation Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.19.5 Stryker Corporation Recent Developments
7.20 Mortara Instrument, Inc.
7.20.1 Mortara Instrument, Inc. Profile
7.20.2 Mortara Instrument, Inc. Main Business
7.20.3 Mortara Instrument, Inc. Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.20.4 Mortara Instrument, Inc. Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.20.5 Mortara Instrument, Inc. Recent Developments
7.21 OSI Systems, Inc.
7.21.1 OSI Systems, Inc. Profile
7.21.2 OSI Systems, Inc. Main Business
7.21.3 OSI Systems, Inc. Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.21.4 OSI Systems, Inc. Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.21.5 OSI Systems, Inc. Recent Developments
7.22 Cardionet Inc.
7.22.1 Cardionet Inc. Profile
7.22.2 Cardionet Inc. Main Business
7.22.3 Cardionet Inc. Cardiac Monitoring & Cardiac Rhythm Management Products, Services and Solutions
7.22.4 Cardionet Inc. Cardiac Monitoring & Cardiac Rhythm Management Revenue (US$ Million) & (2019-2024)
7.22.5 Cardionet Inc. Recent Developments
8 Industry Chain Analysis
8.1 Cardiac Monitoring & Cardiac Rhythm Management Industrial Chain
8.2 Cardiac Monitoring & Cardiac Rhythm Management Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cardiac Monitoring & Cardiac Rhythm Management Sales Model
8.5.2 Sales Channel
8.5.3 Cardiac Monitoring & Cardiac Rhythm Management Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abiomed, Inc.
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
Cardiac Science Corporation
General Electric Company (GE)
Hill-Rom Holdings, Inc.
Jarvik Heart, Inc.
Koninklijke Philips N.V.
LivaNova PLC
Medtronic plc
Nihon Kohden Corporation
ReliantHeart Inc.
SCHILLER AG
Abbott
Siemens AG
3M Company
Asahi Kasei Corporation
Stryker Corporation
Mortara Instrument, Inc.
OSI Systems, Inc.
Cardionet Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.